The Memory Crunch Is Bigger Than Expected. 1 Top Stock to Buy on the Dip (Hint: Not Micron or Sandisk)

Lam Research revenue rose 26% to $23.2B in fiscal 2026 and EPS jumped 39% to $5.76, supported by 46% of sales tied to memory manufacturing equipment. The article projects accelerating growth with guidance for the current quarter: revenue +52% YoY to $8.1B and EPS +71% YoY to $2.15. A severe memory supply crunch—DRAM prices potentially up to 4x by 2026 and supply not easing until 2029–2030—should keep demand for equipment elevated, with analysts forecasting 62% EPS growth in fiscal 2027 to $9.46.

Analysis

The key market mechanism is duration mismatch: memory suppliers monetize price spikes immediately, while LRCX monetizes only when customers convert pricing pain into capex approvals. That makes LRCX a later-cycle beneficiary, but also a cleaner proxy for how persistent the shortage really is. If memory makers keep raising tool spend into 2027, LRCX can compound, but any pause in bookings would hit the stock well before the end-demand narrative breaks.

Second-order winners are the equipment ecosystem and any vendor tied to DRAM/HBM line expansions; second-order losers are AI system integrators and server OEMs facing a higher bill of materials, which can compress deployment ROI even if unit demand stays strong. That matters for NVDA less on volume and more on the risk that memory inflation forces another round of ASP increases, creating friction for hyperscaler budgets and potentially shifting the debate from growth to margin durability.

Contrarian view: the market is likely underpricing how quickly the trade can rotate from "scarcity" to "capex digestion." LRCX has already rerated, so the upside is more dependent on backlog breadth than on the memory price headline. The clean falsifier is a 1-2 quarter stall in memory equipment orders or any evidence that DRAM/NAND pricing is peaking while fab buildouts are still in planning rather than execution; that would argue the 2026-2027 upside is already in the stock.

Key Decisions for Investors

• Long LRCX on a pullback, 6-12 month horizon. Use it as a capped-risk secular capex exposure rather than chasing momentum; upside remains if bookings stay elevated, but a stop is warranted if the next two quarters fail to show order acceleration.
• Relative value: long MU / short LRCX for the next 1-3 months if you want the cleaner earnings revision trade. MU benefits immediately from pricing power, while LRCX needs capex conversion; unwind if LRCX backlog or guidance materially re-accelerates.
• Prefer SNDK only as a tactical momentum expression, not a core hold. The stock is more vulnerable to any rollback in memory prices, so use call spreads or a smaller size if you want exposure to the shortage narrative.
• Watch AMAT and KLAC as confirmation signals over the next quarter. If they do not echo LRCX strength in bookings/commentary, the market is likely overestimating the breadth of the capex cycle.